Literature DB >> 22977464

Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas.

Eva-Maria Fabricius1, Gustav-Paul Wildner, Ute Kruse-Boitschenko, Bodo Hoffmeister, Simon L Goodman, Jan-Dirk Raguse.   

Abstract

Integrins mediate the interaction of cells with the extracellular matrix and are believed to be involved in tumor cell survival and metastasis, and in tumor angiogenesis. We used immunohistochemistry of fresh-frozen human tumor tissues to analyze the presence of integrins αvβ3, αvβ5 and α5β1, which are believed to be involved in tumor growth and migration, together with integrin ligands, vitronectin, osteopontin, fibronectin and fibrinogen, in human oral squamous cell carcinomas. Samples of squamous cell carcinomas and control tissues from patients without cancer undergoing oral or maxillofacial surgery were frozen in liquid nitrogen within 30 min of removal. Frozen sections were prepared, and the presence of integrins or ligands was visualized using standard immunohistochemistry (APAAP) with a blinded evaluation. Comparison of samples from the 40 oral cancer patients and the 20 controls revealed increased staining in tumors compared with the controls, and staining was demonstrated for αvβ3 in endothelia. αvβ5 staining was increased in the tumor samples, but this was associated with increased expression in stroma rather than in endothelia. Modestly increased expression of α5β1 was observed in the tumor samples, and this was associated with tumor cells, endothelia and stroma. Expression of ligands for the integrins varied between tissue types, with increased fibrinogen and fibronectin expression in tumor endothelia. Confirmation of the presence of these integrins and their association with tumor cells, endothelia or stroma suggests their potential for these integrins in human oral tumors. Overall, the increased expression of integrins within tumors, particularly expression associated with endothelial cells, supports the principle of selective integrin blockade as a novel anticancer strategy.

Entities:  

Year:  2010        PMID: 22977464      PMCID: PMC3440681          DOI: 10.3892/etm.2010.171

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  68 in total

Review 1.  Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

Authors:  G J Thomas; M L Nyström; J F Marshall
Journal:  J Oral Pathol Med       Date:  2006-01       Impact factor: 4.253

2.  Implication of alpha5beta1 integrin in invasion of drug-resistant MCF-7/ADR breast carcinoma cells: a role for MMP-2 collagenase.

Authors:  G E Morozevich; N I Kozlova; I B Cheglakov; N A Ushakova; M E Preobrazhenskaya; A E Berman
Journal:  Biochemistry (Mosc)       Date:  2008-07       Impact factor: 2.487

Review 3.  Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.

Authors:  Weibo Cai; Xiaoyuan Chen
Journal:  Anticancer Agents Med Chem       Date:  2006-09       Impact factor: 2.505

4.  alpha5 integrin distribution and TGFbeta1 gene expression in supraglottic carcinoma: their role in neoplastic local invasion and metastasis.

Authors:  D Vitolo; L Ciocci; P Ferrauti; E Cicerone; A Gallo; M De Vincentiis; C D Baroni
Journal:  Head Neck       Date:  2000-01       Impact factor: 3.147

5.  Vascular integrin beta 3 and its relation to pulmonary metastasis of colorectal carcinoma.

Authors:  T Sato; K Konishi; H Kimura; K Maeda; K Yabushita; M Tsuji; A Miwa
Journal:  Anticancer Res       Date:  2001 Jan-Feb       Impact factor: 2.480

6.  Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells.

Authors:  Y Tang; P Borgstrom; J Maynard; J Koziol; Z Hu; A Garen; A Deisseroth
Journal:  Cancer Gene Ther       Date:  2007-01-19       Impact factor: 5.987

7.  Tumours of the head and neck in the elderly: analysis of 190 patients.

Authors:  A D Rapidis; T Keramidas; H Panagiotopoulos; D Andressakis; A P Angelopoulos
Journal:  J Craniomaxillofac Surg       Date:  1998-06       Impact factor: 2.078

Review 8.  Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma.

Authors:  Jarrett E Walsh; Deanne M R Lathers; Angela C Chi; M Boyd Gillespie; Terry A Day; M Rita I Young
Journal:  Curr Treat Options Oncol       Date:  2007-06

9.  Immunohistochemical assessment of the tumour-associated epitopes CD44v6 and E48 in tumour-free lymph nodes from patients with squamous cell carcinoma in the head-neck region.

Authors:  E M Fabricius; M Guschmann; A Langford; B Hell; J Bier
Journal:  Anal Cell Pathol       Date:  2000       Impact factor: 2.916

10.  Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature.

Authors:  Oliver Schnell; Bjarne Krebs; Erika Wagner; Alexander Romagna; Ambros J Beer; Stefan J Grau; Niklas Thon; Claudia Goetz; Hans A Kretzschmar; Jörg-Christian Tonn; Roland H Goldbrunner
Journal:  Brain Pathol       Date:  2008-04-02       Impact factor: 6.508

View more
  22 in total

1.  RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study.

Authors:  Shih-Hsin Chen; Hung-Ming Wang; Chien-Yu Lin; Joseph Tung-Chieh Chang; Chia-Hsun Hsieh; Chun-Ta Liao; Chung-Jan Kang; Lan-Yan Yang; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-27       Impact factor: 9.236

2.  The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.

Authors:  G Heiduschka; C Lill; S Schneider; R Seemann; G Kornek; R Schmid; U Kotowski; D Thurnher
Journal:  Strahlenther Onkol       Date:  2014-02-21       Impact factor: 3.621

Review 3.  Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans.

Authors:  Ihab Atallah; Clément Milet; Jean-Luc Coll; Emile Reyt; Christian Adrien Righini; Amandine Hurbin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-13       Impact factor: 2.503

4.  Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.

Authors:  Muzafar A Macha; Nissar A Wani; Rais A Ganai; Ajaz A Bhat; Abid Hamid; Sheema Hashem; Mohammad Haris; Sham S Chauhan; Mohammad A Zargar; Surinder K Batra
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.

Authors:  Jens Schittenhelm; Annemarie Klein; Marcos S Tatagiba; Richard Meyermann; Falko Fend; Simon L Goodman; Bence Sipos
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 6.  Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.

Authors:  Sabah Nisar; Parvaiz Yousuf; Tariq Masoodi; Nissar A Wani; Sheema Hashem; Mayank Singh; Geetanjali Sageena; Deepika Mishra; Rakesh Kumar; Mohammad Haris; Ajaz A Bhat; Muzafar A Macha
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

7.  Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.

Authors:  J B Vermorken; J Guigay; R Mesia; J M Trigo; U Keilholz; A Kerber; U Bethe; M Picard; T H Brummendorf
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

8.  Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).

Authors:  J B Vermorken; F Peyrade; J Krauss; R Mesía; E Remenar; T C Gauler; U Keilholz; J P Delord; P Schafhausen; J Erfán; T H Brümmendorf; L Iglesias; U Bethe; C Hicking; P M Clement
Journal:  Ann Oncol       Date:  2014-03       Impact factor: 32.976

Review 9.  β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.

Authors:  Anne-Florence Blandin; Guillaume Renner; Maxime Lehmann; Isabelle Lelong-Rebel; Sophie Martin; Monique Dontenwill
Journal:  Front Pharmacol       Date:  2015-11-24       Impact factor: 5.810

10.  VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study.

Authors:  Ipsita Kukreja; Prakhar Kapoor; Revati Deshmukh; Venkatesh Kulkarni
Journal:  J Oral Maxillofac Pathol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.